Advertisement
U.S. Markets open in 2 hrs 54 mins

Aquestive Therapeutics, Inc. (AQST)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Visitors trend2W10W9M
4.9500-0.0800 (-1.59%)
At close: 04:00PM EDT
4.8816 -0.07 (-1.38%)
After hours: 07:33PM EDT
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
58,360
50,583
47,680
50,832
45,849
-
Cost of Revenue
18,392
20,831
19,386
14,989
12,964
-
Gross Profit
39,968
29,752
28,294
35,843
32,885
-
Operating Expense
55,158
44,854
70,360
70,522
75,778
-
Operating Income
-15,190
-15,102
-42,066
-34,679
-42,893
-
Net Non Operating Interest Income Expense
-9,539
8,859
-12,344
-22,038
-12,890
-
Other Income Expense
-
-1,382
-
-13,822
-
-4,896
Pretax Income
-25,758
-7,625
-54,410
-70,539
-55,783
-
Tax Provision
-39
245
0
0
0
-
Net Income Common Stockholders
-25,719
-7,870
-54,410
-70,539
-55,783
-
Diluted NI Available to Com Stockholders
-25,719
-7,870
-54,410
-70,539
-55,783
-
Basic EPS
-0.22
-0.13
-1.12
-1.85
-1.66
-
Diluted EPS
-0.22
-0.13
-1.12
-1.85
-1.66
-
Basic Average Shares
58,053
61,256
48,734
38,078
33,651
-
Diluted Average Shares
59,749
61,256
48,734
38,078
33,651
-
Total Operating Income as Reported
-15,190
-15,102
-42,066
-34,679
-42,893
-
Total Expenses
73,550
65,685
89,746
85,511
88,742
-
Net Income from Continuing & Discontinued Operation
-25,719
-7,870
-54,410
-70,539
-55,783
-
Normalized Income
-24,692
-6,533
-54,410
-56,734
-55,783
-
Interest Income
3,403
16,321
99
423
132
-
Interest Expense
12,942
7,462
12,443
22,461
13,022
-
Net Interest Income
-9,539
8,859
-12,344
-22,038
-12,890
-
EBIT
-12,816
-163
-41,967
-48,078
-42,761
-
EBITDA
-11,673
1,182
-39,580
-45,114
-39,318
-
Reconciled Cost of Revenue
18,392
20,831
19,386
14,989
12,964
-
Reconciled Depreciation
1,143
1,345
2,387
2,964
3,443
-
Net Income from Continuing Operation Net Minority Interest
-25,719
-7,870
-54,410
-70,539
-55,783
-
Total Unusual Items Excluding Goodwill
-1,029
-1,382
0
-13,822
0
-
Total Unusual Items
-1,029
-1,382
0
-13,822
0
-
Normalized EBITDA
-10,644
2,564
-39,580
-31,292
-39,318
-
Tax Rate for Calcs
0
0
0
0
0
-
Tax Effect of Unusual Items
-1.558
-44.5004
0
-16.5864
0
-